Drug class · Hematology
Anticoagulants
Drugs that reduce blood clotting, including factor Xa inhibitors, low-molecular-weight heparins and other anticoagulants.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| fondaparinux sodium | Fondaparinux sodium 7.5 mg/.6mL | Injection, SolutionSubcutaneous | Zydus Pharmaceuticals (USA) Inc. | 70710-1516 |
| fondaparinux sodium | Fondaparinux sodium 10 mg/.8mL | Injection, SolutionSubcutaneous | Zydus Pharmaceuticals (USA) Inc. | 70710-1517 |
| fondaparinux sodium | Fondaparinux sodium 5 mg/.4mL | Injection, SolutionSubcutaneous | Italfarmaco S.p.A | 11797-155 |
| fondaparinux sodium | Fondaparinux sodium 2.5 mg/.5mL | Injection, SolutionSubcutaneous | Italfarmaco S.p.A | 11797-154 |
| fondaparinux sodium | Fondaparinux sodium 7.5 mg/.6mL | Injection, SolutionSubcutaneous | Italfarmaco S.p.A | 11797-156 |
| fondaparinux sodium | Fondaparinux sodium 10 mg/.8mL | Injection, SolutionSubcutaneous | Italfarmaco S.p.A | 11797-157 |
| rivaroxaban | Rivaroxaban 15 mg/1 | Tablet, Film coatedOral | Changzhou Pharmaceutical Factory | 55488-0541 |
| rivaroxaban | Rivaroxaban 10 mg/1 | Tablet, Film coatedOral | Changzhou Pharmaceutical Factory | 55488-0540 |
| rivaroxaban | Rivaroxaban 20 mg/1 | Tablet, Film coatedOral | Changzhou Pharmaceutical Factory | 55488-0542 |
| rivaroxaban | Rivaroxaban 2.5 mg/1 | TabletOral | Florida Pharmaceutical Products, LLC | 71921-405 |
| rivaroxaban granule | Rivaroxaban 155 mg/1 | For suspensionOral | Lupin Pharmaceuticals, Inc. | 70748-355 |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1anhydrous citric acid, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate, dextrose monohydrate, and adenine | Anhydrous citric acid 2.99 g/1000mL + 4 more ingredients | SolutionIntravenous | Terumo Corporation | 53877-110 |
| triCitrasoltrisodium citrate dihydrate | Trisodium citrate dihydrate 14 g/30mL | SolutionExtracorporeal | Citra Labs LLC | 23731-6030 |